Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F64K9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,584
Award facts
- Contract value 100% obligated
- $32,583.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32,583.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on December 24, 2025, with an ultimate completion date of December 26, 2025. This competitively awarded, non-set-aside contract utilizes AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
Mounjaro is a diabetes medication used for glycemic control in type 2 diabetes treatment. AmerisourceBergen, a major pharmaceutical distributor serving federal medical procurement needs, maintains an extensive portfolio of delivery orders with the Defense Logistics Agency covering diverse therapeutic domains including endocrinology, neurology, pain management, and infectious disease treatments. This particular delivery order represents a routine fulfillment within the company's broader medical supply chain operations supporting the Defense Health Agency and other federal healthcare systems. The contract reflects AmerisourceBergen's demonstrated capability to meet federal procurement requirements through competitive bidding and efficient pharmaceutical distribution.
Quick answers
Who was awarded contract SPE2DR26F64K9?
SPE2DR26F64K9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 24, 2025.
How much is contract SPE2DR26F64K9 worth?
The government has obligated $32,584 on SPE2DR26F64K9.
Is contract SPE2DR26F64K9 an order under another contract?
Yes. SPE2DR26F64K9 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F64K9 competed?
The extent of competition for SPE2DR26F64K9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award